Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient

Dolutegravir: A Next-Generation Integrase Inhibitor for Treatment of HIV Infection

(2014) D. A. Osterholzer et al.   CLINICAL INFECTIOUS DISEASES

Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

(2014) Eve-Irene Lepist et al.   KIDNEY INTERNATIONAL

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

(2013) Mackenzie L. Cottrell et al.   CLINICAL PHARMACOKINETICS

Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV

(2013) Bhavik M. Shah et al.   PHARMACOTHERAPY

The 2013 WHO guidelines for antiretroviral therapy

(2013) Meg Doherty et al.   Current Opinion in HIV and AIDS

A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects

(2012) Justin Koteff et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

HIV treatment as prevention and HPTN 052

(2012) Myron S. Cohen et al.   Current Opinion in HIV and AIDS